The Medtronic phased RF portfolio item (REF 5570286034RF) is positioned within the company's electrophysiology (EP) capital equipment line, designed to support cardiac ablation workflows that combine cryoablation system compatibility with phased radiofrequency (RF) technology. This catalog entry is intended for B2B procurement by hospitals, cardiac catheterization labs, and EP service providers sourcing Medtronic-branded capital equipment and accessories.
Key Features
Phased RF technology architecture associated with Medtronic's EP capital equipment portfolio.
Catalog alignment with Medtronic CryoAblation / cryoballoon ecosystem references.
Manufacturer reference number 5570286034RF for procurement traceability.
Designed for integration into established Medtronic EP capital equipment workflows.
Detailed technical specifications: Not specified in the located sources.
Clinical Applications
Intended for use within cardiac electrophysiology procedure environments where Medtronic phased RF and cryoablation platforms are deployed. Specific approved clinical indications, patient populations, and procedural protocols: Not specified in the located sources. Clinical suitability must be confirmed against the current manufacturer Instructions for Use (IFU) and applicable regulatory clearances in the buyer's jurisdiction.
Product Information
Brand: Medtronic
Category: EP Capital Equipment
REF/UPN: 5570286034RF
Product family: Phased RF portfolio / Cryoablation system-related
Dimensions, weight, power requirements, sterilization status, single-use vs reusable classification: Not specified in the located sources
Regulatory clearances (FDA, CE, others): Not specified in the located sources
Country of origin and packaging configuration: Not specified in the located sources